Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes
Klev Diamanti(Uppsala University), Håkan Åhlström(Uppsala University), Ulf Risérus(Uppsala University), Marco Cavalli(Uppsala University), Jan W. Eriksson(Uppsala University Hospital), Gang Pan(Uppsala University), Jan Komorowski(Linnaeus University), Stanko Skrtic(Sahlgrenska University Hospital), Claes Wadelius(Uppsala University), Joel Kullberg(Uppsala University), Maria J. Pereira(Uppsala University), Chanchal Kumar(Vignana Jyothi Institute of Management), Robin Visvanathar(Uppsala University)
Cited by 12
Related Papers
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
|Science|2009|4.1k
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
|Science Signaling|2010|1.5k
Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
|Proceedings of the National Academy of Sciences|1999|956
Dietary fats and prevention of type 2 diabetes
|Progress in Lipid Research|2008|762